Updates in Management of Cirrhosis: What the Hospitalists Should Know-Slides

Slides

Pdf Summary

This 2024 overview by Dr. Simona Jakab highlights key hospitalist knowledge for managing cirrhosis, emphasizing updated clinical approaches to decompensated liver disease. Cirrhosis progresses through compensated, first decompensation (ascites, variceal bleeding, encephalopathy), and further decompensated stages, with portal hypertension playing a central role in complications.<br /><br />Key management guidelines include recent AGA, AASLD, and EASL recommendations on vasoactive drugs, TIPS/RTO procedures, AKI, hepatic encephalopathy, ascites, spontaneous bacterial peritonitis (SBP), and hepatorenal syndrome (HRS).<br /><br />Portal hypertension results from mechanical fibrosis and functional vasoconstriction, causing ascites, variceal bleeding, and encephalopathy. Interventional radiology procedures—TIPS for portal decompression, BRTO for variceal obliteration—are essential treatment modalities.<br /><br />Hemostasis in cirrhosis is rebalanced, with conventional labs like INR and platelet counts insufficient for bleeding risk assessment; global viscoelastic testing is preferable. Diagnostic paracentesis for ascites is safe without routine blood product transfusions even with elevated INR/low platelets.<br /><br />Ascites management focuses on both symptomatic control (salt restriction, diuretics, large volume paracentesis) and prevention of further decompensation, including etiologic treatments, nonselective beta blockers, TIPS, and consideration of albumin or antibiotics to address bacterial translocation. SBP requires prompt paracentesis and antibiotics plus intravenous albumin to improve survival.<br /><br />AKI in cirrhosis is defined by dynamic serum creatinine changes; causes include prerenal azotemia, HRS, and ATN. Early use of vasoconstrictors, especially terlipressin with close monitoring, alongside albumin but avoiding excessive doses, improves outcomes. Midodrine/octreotide is no longer recommended due to low efficacy.<br /><br />Hepatic encephalopathy management involves identifying precipitating factors, lactulose to achieve 2-3 soft bowel movements daily, and rifaximin for secondary prophylaxis. Refractory cases may require interventional closure of porto-systemic shunts.<br /><br />Variceal bleeding necessitates acute stabilization, local control via banding, and risk-directed secondary prevention with NSBB or TIPS in high-risk patients.<br /><br />Preoperative evaluation must stratify surgical risk based on cirrhosis stage and surgery type; optimization includes managing ascites, renal function, encephalopathy, and avoiding unnecessary correction of coagulopathy or excessive transfusions.<br /><br />Overall, current care emphasizes staging cirrhosis by complications, employing evidence-based pathways, preventing further decompensation, and integrating palliative care when appropriate to improve quality and outcomes.

Keywords

cirrhosis management

decompensated liver disease

portal hypertension

TIPS procedure

hepatic encephalopathy

spontaneous bacterial peritonitis

acute kidney injury in cirrhosis

variceal bleeding

ascites treatment

preoperative evaluation in cirrhosis